Market Snapshot:
Additive manufacturing includes 3D printing. Although there are various methods of additive manufacturing, the phrases 3D printing and additive manufacturing are frequently interchanged. For the sake of simplicity, we'll refer to both as 3D printing. 3D printing is a technique for creating three-dimensional objects by layering raw materials together. Until the object is complete, each new layer is attached to the previous one. A digital 3D file, such as a computer-aided design (CAD) drawing or a Magnetic Resonance Image, is used to create objects (MRI). Designers can simply make adjustments thanks to the versatility of 3D printing, which eliminates the need for additional equipment or tools. It also allows manufacturers to produce devices that are tailored to the anatomy of a certain patient (patient-specific devices) or devices with extremely complicated internal architecture. These capabilities have spurred a surge in interest in 3D printing medical equipment and other things, such as food, household items, and vehicle parts.
Highlights from Healthcare Additive Manufacturing Market Study
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The key Players profiled in the report are 3D Systems (United States), Allevi (United States), EOS (Germany), GE Additive (United States), Materialise (Belgium), Stratasys (United States), Xometry Inc. (United States), Protolabs (United States), Velo3D Inc. (United States) and Desktop Metal Inc. (United States. Additionally, other players that are part of this comprehensive study are Nano Dimension (United States), Markforged Holding Corp. (United States), Shapeways Holdings Inc. (Netherlands), MeaTech 3D Ltd. (Israel), Organovo Holding Inc. (United States) and Voxeljet (Germany).
Geographic Breakdown and Segment Analysis
The Global Healthcare Additive Manufacturing market presents a comprehensive analysis of the Healthcare Additive Manufacturing market by end-user/application (Medical Implants, Prosthetics, Wearable Devices, Tissue Engineering and Others), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global Healthcare Additive Manufacturing industry. Investors and Players can easily understand the inherent opportunities and challenges for their products in geographical region of interest.
For instance, while the holds majority of market share of the Healthcare Additive Manufacturing market
Analyst at AMA have segmented the market study of Global Healthcare Additive Manufacturing market by Type, Application and Region.
Influencing Trend:
An increase in Demand for Specialized Implants has been on Latest Trends in This Which Is Contributing to Market Growth.
Market Growth Drivers:
The Technological Advanced Way of 3D printing with a Cost-Effective Manner Has Been Driving the Market Growth.
Challenges:
High Initial Investment to Increase Potential Scalability.
Restraints:
Making a Model Through 3D Printers has Limitations Including Errors throughout the Step By Step Process.
Opportunities:
Additive Manufacturing Brings Convenience to Manufacture Complex Designs in Low Cost Which Will Drive Growth in Future.
Market Developments Activities:
3D Systems in October 2021 announced the acquisition of Volumetric Biotechnologies, a Houston-based biotech company co-founded by Drs. Jordan Miller and Bagrat Grigoryan. Volumetric’s mission has from the outset been to develop the ability to manufacture human organs using bioprinting methods. Dr. Miller and his team of bioengineers and scientists have made tremendous progress in these efforts, focusing primarily on the human liver and the underlying technologies required to create these highly complex biological structures. With this acquisition, 3D Systems plans to establish a world-class research capability in Houston, Texas, a region committed to leadership in technologies related to life sciences.
3D Systems May 2021 announced it will increase its presence in Denver, Colorado to support its fast-growing healthcare solutions business, and expand industrial application development capabilities for its Application Innovation Group (AIG). This activity is a continuation of the investment phase of the company’s plan to focus on its strategic purpose as the leader in enabling additive manufacturing solutions for applications in growing markets that demand high-reliability products.
Regulatory Insights:
FDA Design and manufacturing Process Considerations for class II and class III devices and select class I devices, manufacturers must establish and maintain procedures to control the design of the device in order to ensure that specified design requirements are met per 21 CFR 820.30 Design Controls. Manufacturers must also establish and maintain procedures for monitoring and control of process parameters for validated processes to ensure that the specified requirements continue to be met. Where the results of a process cannot be fully verified by subsequent inspection and test, the process must be validated with a high degree of assurance and approved according to established procedures.
The Healthcare additive manufacturing market has had its share of growth in technology which made many new players join and drive growth in this market whereas the existing players through massive investments in R&D have helped the market is growing at a steady rate and also by rising adoption of strategies by key players. The healthcare additive manufacturing market through many applications like medical implants and more has a sufficient market share to drive the market well and thus major players are also exploring mergers and acquisitions and investments also are launching new and better services.
Key Target Audience
Additive Manufacturing firms, Health care institutions, New Entrants and Investors, Legalized Cannabis Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others